← Evidence map

ArticleLeukemia & lymphoma2020

Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection.

Claudio Galvao de Castro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32611256